Related Experiment Videos
Fundus changes in patients with the mitochondrial DNA point mutation at position 3243
1Department of Ophthalmology, University Hospitals of Leuven, Belgium.
Abstract:
The A3243G transition in the mitochondrial DNA is commonly associated with the syndrome of mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Previously, atypical pigmentary retinopathy has been described in patients with this syndrome and in patients with other phenotypes of the same mitochondrial defect. Maternally inherited diabetes mellitus and deafness has been recognized as a distinct clinical presentation of the mitochondrial point mutation at position 3243, and recently a pattern dystrophy has been identified as a characteristic ocular abnormality in these patients. The finding of a macular pattern dystrophy in patients with diabetes should therefore lead to screening for this aberrant mitochondrial genome.
Insights
The A3243G mitochondrial DNA mutation is linked to MELAS syndrome. Macular pattern dystrophy in diabetic patients may indicate this mutation, prompting genetic screening.
Area of Science:
- Genetics
- Ophthalmology
- Neurology
Background:
- The A3243G mitochondrial DNA mutation is a known cause of MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes).
- Ocular manifestations, including atypical pigmentary retinopathy, have been observed in patients with this mutation.
- Maternally inherited diabetes and deafness is a recognized phenotype associated with the A3243G mutation.
Observation:
- A pattern dystrophy has been identified as a characteristic ocular abnormality in patients with maternally inherited diabetes and deafness due to the A3243G mutation.
- This macular pattern dystrophy can serve as a clinical indicator for the underlying mitochondrial defect.
Findings:
- The presence of macular pattern dystrophy in individuals with diabetes warrants investigation for the A3243G mitochondrial DNA mutation.
- This finding links a specific ocular sign to a distinct clinical presentation of mitochondrial disease.
Implications:
- Screening for the A3243G mitochondrial genome should be considered in diabetic patients presenting with macular pattern dystrophy.
- Early identification of this mitochondrial defect can facilitate timely diagnosis and management of associated conditions.
- This research highlights the importance of ophthalmological examination in the broader diagnostic workup of mitochondrial disorders.